logo
Plus   Neg
Share
Email

Galena Biopharma CEO Mark Ahn Steps Down; Names Mark Schwartz Replacement

Galena Biopharma Inc. (GALE) Thursday said Mark Ahn, its President and Chief Executive Officer, has resigned from the company to pursue other goals. Mark Schwartz will take over the position, effective immediately.

Previously, Schwartz was Galena's Executive Vice President and Chief Operating Officer. He has over 30 years of experience in the biotechnology and life science industry. Before joining Galena, he had served in the roles of President and Chief Executive at Apthera Inc. and at Bayhill Therapeutics. He was also the President and CEO of Calyx Therapeutics, which expanded significantly, and completed key Phase 1 and Phase 2 international clinical trials of novel anti-inflammatory compounds during his tenure.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Chinese e-commerce giant Alibaba Group Holding Limited and rival JD.com have set new sales records for the "Singles Day" online shopping event. Alibaba said Sunday that it generated gross merchandise volume or GMV of 213.5 billion yuan, or $30.8 billion on November 11, 2018, representing an increase of 27 percent compared to 2017. The Singles Day shopping festival began in 2009. Japanese conglomerate SoftBank Group Corp. said Monday it has received approval from the Tokyo Stock Exchange for listing of common stock of its Japanese mobile telecoms unit, SoftBank Corp. SoftBank plans to sell shares worth 2.4 trillion yen, or $21 billion, in its domestic mobile telecom unit. This would make it the world's biggest IPO after Alibaba's $25 billion IPO in 2014. Shares of Infineon Technologies AG were losing around 4 percent in the morning trading in Germany after the semiconductor solutions company reported Monday weak net profit in its fourth quarter. Income from continuing operations, however, grew with strong revenue growth. The company also increased its full-year dividend.
Follow RTT